Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EGFR Wildtype”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Large-scale testing (Phase 3)UnknownNCT02332512
What this trial is testing

Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jiangsu HengRui Medicine Co., Ltd. 417
Large-scale testing (Phase 3)Not Yet RecruitingNCT07442565
What this trial is testing

SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase Ⅲ

Who this might be right for
Non-Small Cell Lung Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 506
Testing effectiveness (Phase 2)WithdrawnNCT03240393
What this trial is testing

Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
CarcinomaNon-Small-Cell Lung Cancer
Novartis Pharmaceuticals
Not applicableUnknownNCT03263663
What this trial is testing

Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model

Who this might be right for
Colo-rectal CancerRAS Wild-typeUICC III+2 more
PD Dr. med. Volker Heinemann 1,000
Not applicableStudy completedNCT04466267
What this trial is testing

The Molecular Mechanism of RAS Wild-type mCRC Resistance to Anti-EGFR-antibody

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 40
Early research (Phase 1)Study completedNCT01255657
What this trial is testing

ABT-806 in Subjects With Advanced Solid Tumor Types

Who this might be right for
Advanced Solid Tumors
AbbVie (prior sponsor, Abbott) 49
Testing effectiveness (Phase 2)Study completedNCT01003899
What this trial is testing

A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR]

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 43
Testing effectiveness (Phase 2)Study completedNCT00418938
What this trial is testing

SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial

Who this might be right for
CancerColon CancerColorectal Cancer+3 more
Amgen 266
Large-scale testing (Phase 3)Study completedNCT05427305
What this trial is testing

TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Efficacy
BioDlink Biopharm Co., Ltd. 549
Testing effectiveness (Phase 2)Looking for participantsNCT05694936
What this trial is testing

Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Australasian Gastro-Intestinal Trials Group 90
Large-scale testing (Phase 3)UnknownNCT01579630
What this trial is testing

Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy

Who this might be right for
NSCLC
Taipei Veterans General Hospital, Taiwan 52
Testing effectiveness (Phase 2)UnknownNCT03405272
What this trial is testing

Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC

Who this might be right for
Metastatic Colorectal Cancer
Sinocelltech Ltd. 110
Testing effectiveness (Phase 2)UnknownNCT01312337
What this trial is testing

Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Nonsmall Cell Lung Cancer
Samsung Medical Center 92
Testing effectiveness (Phase 2)Ended earlyNCT02556593
What this trial is testing

IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases

Who this might be right for
Non-Small Cell Lung Carcinoma
Sun Yat-sen University 12
Testing effectiveness (Phase 2)Ended earlyNCT02323126
What this trial is testing

Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Novartis Pharmaceuticals 64
Testing effectiveness (Phase 2)UnknownNCT02191059
What this trial is testing

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shandong Cancer Hospital and Institute 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06554613
What this trial is testing

Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University 156
Testing effectiveness (Phase 2)UnknownNCT03863483
What this trial is testing

Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy.

Who this might be right for
Nonsquamous Non-Small Cell Lung Cancer
Xin-Hua Xu 70
Testing effectiveness (Phase 2)UnknownNCT03201146
What this trial is testing

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Who this might be right for
Lung CancerNon Small Cell Lung CancerCombination Chemotherapy+1 more
West China Hospital 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05374603
What this trial is testing

Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC

Who this might be right for
Lung Cancer
AstraZeneca 47
Load More Results